300255.SZ
300255.SZ
CNE1000016C2
CHANGSHAN PHARMA
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 875.132.347 1.030.810.533
15.1%
Cost of Revenue 742.718.973 864.815.799
14.1%
Gross Profit 132.413.373 165.994.734
20.2%
225.213.737 262.613.132
14.2%
Operating Income -92.800.364 -96.618.398
4.0%
Pretax Income -355.891.603 -257.078.606
38.4%
Net Income Common Stockholders -357.895.551 -249.477.726
43.5%
-- --
--
-- --
--
ende